Alan W Dunton - Net Worth and Insider Trading
Alan W Dunton Net Worth
The estimated net worth of Alan W Dunton is at least $209,924 dollars as of 2024-11-05. Alan W Dunton is the Director of Cormedix Inc and owns about 15,250 shares of Cormedix Inc (CRMD) stock worth over $154,483. Alan W Dunton is the Director of Palatin Technologies Inc and owns about 45,074 shares of Palatin Technologies Inc (PTN) stock worth over $55,441. Alan W Dunton is also the Director of Catalyst Biosciences Inc and owns about 0 shares of Catalyst Biosciences Inc (CBIO) stock worth over $0. Details can be seen in Alan W Dunton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan W Dunton has not made any transactions after 2023-12-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan W Dunton
Alan W Dunton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan W Dunton owns 6 companies in total, including Cormedix Inc (CRMD) , Palatin Technologies Inc (PTN) , and Oragenics Inc (OGEN) among others .
Click here to see the complete history of Alan W Dunton’s form 4 insider trades.
Insider Ownership Summary of Alan W Dunton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRMD | Cormedix Inc | 2023-12-15 | director |
| PTN | Palatin Technologies Inc | 2023-12-04 | director |
| OGEN | Oragenics Inc | 2015-12-15 | director |
 | | 2015-08-04 | director |
| | 2013-08-12 | director |
| | 2006-05-11 | director |
Alan W Dunton Latest Holdings Summary
Alan W Dunton currently owns a total of 3 stocks. Among these stocks, Alan W Dunton owns 15,250 shares of Cormedix Inc (CRMD) as of December 15, 2023, with a value of $154,483 and a weighting of 73.59%. Alan W Dunton owns 45,074 shares of Palatin Technologies Inc (PTN) as of December 4, 2023, with a value of $55,441 and a weighting of 26.41%. Alan W Dunton also owns 0 shares of Catalyst Biosciences Inc (CBIO) as of August 2, 2010, with a value of $0 and a weighting of 0%.
Latest Holdings of Alan W Dunton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRMD | Cormedix Inc | 2023-12-15 | 15,250 | 10.13 | 154,483 |
| PTN | Palatin Technologies Inc | 2023-12-04 | 45,074 | 1.23 | 55,441 |
| CBIO | Catalyst Biosciences Inc | 2010-08-02 | 0 | 7.67 | 0 |
Holding Weightings of Alan W Dunton
Alan W Dunton Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan W Dunton has made a total of 3 transactions in Cormedix Inc (CRMD) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Cormedix Inc is the acquisition of 6,000 shares on December 15, 2023, which cost Alan W Dunton around $20,280.
According to the SEC Form 4 filings, Alan W Dunton has made a total of 2 transactions in Palatin Technologies Inc (PTN) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Palatin Technologies Inc is the sale of 200 shares on December 4, 2023, which brought Alan W Dunton around $496.
According to the SEC Form 4 filings, Alan W Dunton has made a total of 0 transactions in Catalyst Biosciences Inc (CBIO) over the past 5 years. The most-recent trade in Catalyst Biosciences Inc is the sale of 57 shares on August 2, 2010, which brought Alan W Dunton around $133,800.
Insider Trading History of Alan W Dunton
- 1
Alan W Dunton Trading Performance
GuruFocus tracks the stock performance after each of Alan W Dunton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan W Dunton is 15.63%. GuruFocus also compares Alan W Dunton's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan W Dunton within 3 months outperforms 8 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alan W Dunton's insider trading performs compared to the benchmark.
Performance of Alan W Dunton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.65 | | | | | |
| Relative Return to S&P 500(%) | 10.57 | | | | | |
Alan W Dunton Ownership Network
Ownership Network List of Alan W Dunton
Ownership Network Relation of Alan W Dunton
Alan W Dunton Owned Company Details
What does Cormedix Inc do?
Who are the key executives at Cormedix Inc?
Alan W Dunton is the director of Cormedix Inc. Other key executives at Cormedix Inc include director & Chief Executive Officer Joseph Todisco , Chief Commercial Officer Erin Mistry , and EVP & Chief Financial Officer Matthew T David .
Cormedix Inc (CRMD) Insider Trades Summary
Over the past 18 months, Alan W Dunton made 2 insider transaction in Cormedix Inc (CRMD) with a net purchase of 9,000. Other recent insider transactions involving Cormedix Inc (CRMD) include a net purchase of 28,561 shares made by Joseph Todisco , a net purchase of 10,000 shares made by Paulo F Costa , and a net purchase of 10,000 shares made by Robert A Stewart .
In summary, during the past 3 months, insiders sold 0 shares of Cormedix Inc (CRMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cormedix Inc (CRMD) were sold and 64,561 shares were bought by its insiders, resulting in a net purchase of 64,561 shares.
Cormedix Inc (CRMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cormedix Inc Insider Transactions
Alan W Dunton Mailing Address
Above is the net worth, insider trading, and ownership report for Alan W Dunton. You might contact Alan W Dunton via mailing address: Vicuron Pharmaceuticals Inc, 455 S Gulph Road Suite 305, King Of Prussia Pa 19406.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
